Craig MartinFounder, CEO at Orphan Therapeutics AcceleratorSpeaker
Profile
Craig is a deeply experienced executive, advisor and board director, with extensive background in biotech and health technology fields. His focus in emerging innovation and desire to make an impact have led to a longstanding commitment to supporting rare disease communities. Craig has led for-profit and non-profit organizations focused on advancing and expanding access to treatments for rare, genetic conditions and is a frequent speaker and commentator on overcoming market and policy challenges facing innovators and caregivers and patients with rare diseases.
Agenda Sessions
Leveraging AI in Rare Disease – Practical Applications to Transform Strategy
, 9:15amView Session
